This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US

Early Bird Savings and Poster Submission Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
September 27-30, 2022
Boston Convention and Exhibition CenterBoston, MA

Øystein Åmellem, PhD
Director, Cell Biology at Thermo Fisher Scientific


Dr. Øystein Åmellem has held leadership positions in research and development, product management, and business for over 21 years at Thermo Fisher Scientific. Øystein is responsible for development and commercialization of products and services, including many for the cell therapy market. His training is in the field of molecular cell biology, having received his PhD from the University of Oslo. Øystein’s academic career focused on the study of physiological and molecular mechanisms of tumor cell growth and involved investigating the method of actions for a novel group of anticancer compounds developed by Norsk Hydro.

Agenda Sessions

  • Implementing Automated, Closed and Integrated Systems in Cell Therapy Manufacturing